Original Literature | Model OverView |
---|---|
Publication
Title
Toll-like receptors: from the discovery of NFkappaB to new insights intotranscriptional regulations in innate immunity.
Affiliation
School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2,Ireland. doylesl@tcd.ie
Abstract
Toll-like receptors (TLRs) are key components of the innate immune system,functioning as pattern recognition receptors that recognise a wide range ofmicrobial pathogens. TLRs represent a primary line of defence against invadingpathogens in mammals, plants and insects. Recognition of microbial components byTLRs triggers a cascade of cellular signals that culminates in the activation ofNFkappaB which leads to inflammatory gene expression and clearance of theinfectious agent. The history of NFkappaB began with the TLR4 ligandlipopolysaccharide (LPS), a component of the cell wall of Gram-negativebacteria, since this was the stimulus first used to activate NFkappaB inpre-B-cells. However, since those early days it has been a circuitous route,made possible by drawing on information provided by many different fields, thathas led us not only to the discovery of TLRs but also to an understanding of thecomplex pathways that lead from TLR ligation to NFkappaB activation. In thisreview we will summarize the current knowledge of TLR-mediated NFkappaBactivation, and also the recent discoveries that subtle differences in kappaBbinding sequences and NFkappaB dimer formation result in specific geneexpression profiles.
PMID
16930560
|
Entity
Process
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
TBK1{active}
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
TLR2
--
MO000019397
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3964
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019397 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6255
10
infinite
0
TRANSPATH | MO000021929 |
--
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
IP-10
--
e10
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m10
0
infinite
0
--
IRF3:IP-10
--
e100
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m101
0
infinite
0
--
IP-10
--
e101
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m102
0
infinite
0
--
IFN-beta:IRF3
--
e102
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m103
0
infinite
0
--
LPS:TLR4:TRAM
--
e103
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m104
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e104
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m105
0
infinite
0
--
IRF3:p65
--
e106
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m107
0
infinite
0
--
Glucocorticoids
--
e107
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m108
0
infinite
0
--
IRG-1
--
e108
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m109
0
infinite
0
--
GARG16
--
e109
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m110
0
infinite
0
--
Triacylated lipopeptides
--
e11
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m11
0
infinite
0
--
Src kinases
--
e110
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m111
0
infinite
0
--
NF-kappaB{active}
--
e111
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m112
10
infinite
0
TRANSPATH | MO000000058 |
--
TLR1:TLR2:Triacylated lipopeptides
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
TLR2:TLR6
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
diacylated lipopeptides
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
TLR2:TLR1:diacylated lipopeptides
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
TLR5:flagellin
--
e16
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m16
0
infinite
0
--
ssRNA
--
e17
cso30:c:Rna
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
TLR7:ssRNA
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m18
0
infinite
0
--
TLR8:ssRNA
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CpG motifs
--
e20
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m20
0
infinite
0
--
TLR9:CpG motifs
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m21
0
infinite
0
--
fungal, protozoal products
--
e22
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m22
0
infinite
0
--
TLR2:fungal,protozoal products
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
NF-KappaB:IKappaB
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
IRAK1{p}:TRAF6{ub}:TAK1{ub}{p}:TAB2{p}:TAB1
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
LPS:TLR4
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
LPS:TLR4:MyD88:TIRAP
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
LPS:TLR4:MyD88:IRAK4
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
IRAK1
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
LPS:TLR4:MyD88:IRAK4:IRAK1{p}
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
LPS:TLR4:MyD88:IRAK4:IRAK1
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
IRAK1{p}
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
LPS:TLR4:MyD88:IRAK4
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
IRAK1{p}:TRAF6
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
TAK1
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
TAK1:TAB1:TAB2
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IRAK1{p}:TRAF6:TAK1:TAB1:TAB2
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
IRAK1{p}:TRAF6{ub}:TAK1{ub}:TAB1:TAB2
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
IRAK1{p}:TRAF6{ub}:TAK1{ub}{p}:TAB2{p}:TAB1
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
TRAF6{ub}:TAK1{ub}{p}:TAB2{p}:TAB1
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
proteosome remnants
--
e44
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
--
e46
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m47
0
infinite
0
--
--
e47
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m48
0
infinite
0
--
--
e48
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m49
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
LPS:TLR4
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TLR1:TLR2
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
RIP1
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1:TRAF6
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
LPS:TLR4:MyD88
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
LPS:TLR4:MyD88:TIRAP:Btk
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
LPS:TLR4:MyD88:TIRAP:Btk{p}
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
LPS:TLR4:MyD88:TIRAP{p}:Btk{p}
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
NF-kappaB
--
e70
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m71
10
infinite
0
TRANSPATH | MO000000058 |
--
IKBZ
--
e71
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m72
0
infinite
0
--
TNFalpha gene
--
e72
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m73
0
infinite
0
--
NFKappaB:TNFalpha
--
e73
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m74
0
infinite
0
--
IL-1gene
--
e74
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m75
0
infinite
0
--
IL-1:NFKappaB
--
e75
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m76
0
infinite
0
--
IL-2 gene
--
e76
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m77
0
infinite
0
--
IL-2:NFKappaB
--
e77
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m78
0
infinite
0
--
IL-1
--
e78
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m79
0
infinite
0
--
Il-8
--
e79
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
Il-1
--
e80
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m81
0
infinite
0
--
NF-KappaB:IKappaB{p}
--
e81
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
proteosome remnants
--
e82
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m83
0
infinite
0
--
PTKs
--
e83
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
NF-kappaB{p}
--
e84
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m85
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF-alpha receptor
--
e85
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m86
0
infinite
0
--
TNF-alpha:receptor
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m87
0
infinite
0
--
Il-1R
--
e87
cso30:c:Protein
cso30:i:CC_PlasmaMembrane
--
--
csml-variable:Double
m88
0
infinite
0
--
IL-1:receptor
--
e88
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m89
0
infinite
0
--
PKA
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
NFKappaB{p}:CBP
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m91
0
infinite
0
--
NFKappaB{p}:CBP
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
NFKappaB:CBP:IKBZ
--
e92
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m93
0
infinite
0
--
IKBZ
--
e93
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m94
0
infinite
0
--
dsRNA:TLR3:TRIF:TBK1
--
e94
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m95
0
infinite
0
--
dsRNA:TLR3:TRIF:IKK-i
--
e95
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m96
0
infinite
0
--
IRF-3{active}
--
e96
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m97
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-3:IRF-3
--
e97
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m98
0
infinite
0
--
IRF-3:IRF-3
--
e98
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m99
0
infinite
0
--
IFN-beta
--
e99
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m100
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
m155666*m3985*0.1
nodelay
--
0
PMID: 16930560 LPS was known to be concentrated from the plasma by LPS binding protein (LBP), and CD14 was identified as a receptor for LPS on the surface of the cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m20*m19828*0.1
nodelay
--
0
PMID: 16930560 The anti-viral TLRs are TLR3 which recognises double stranded RNA, TLR7 and TLR8 which bothrecognise single strandedRNA,andTLR9which recognises CpGmotifs, that exist in both virus and bacteria
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m3964*m22*0.1
nodelay
--
0
PMID: 16930560 Finally various fungal and protozoal products are sensed by TLR2.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c111 : 1
m24*m186*0.1
nodelay
--
0
PMID: 16930560 As is now well known, NFkB is regulated by an inhibitory molecule called inhibitory kB (IkB) which retains NFkB in the cytoplasm under normal conditions.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m43*0.1
nodelay
--
0
PMID: 16930560,11518704,12242293 Phosphorylation of TAK1 and TAB2 occurs initiating the dissociation of TRAF6/TAK1/TAB1/TAB2 from the membrane to the cytosol, and IRAK-1 degradation PMID: 16930560,11460167,11518704,12242293 Ubiquitination of TRAF6 and TAK1 activate the complex, and phosphorylation of TAK1 and TAB2 initiates the release of the complex from the membrane
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c57 : 1
m92*m73*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m5*0.1
nodelay
--
0
PMID: 16930560 On TLR ligation, TLR4 dimers and TLR2 heterodimerised with TLR1 or TLR6 recruit Mal and MyD88 to their TIR domains, TLR7/8/9 recruit MyD88 alone.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c99 : 1
m30*m1572*0.1
nodelay
--
0
PMID: 16930560 On TLR ligation, TLR4 dimers and TLR2 heterodimerised with TLR1 or TLR6 recruit Mal and MyD88 to their TIR domains, TLR7/8/9 recruit MyD88 alone. PMID: 16930560 MyD88, which has a C-terminal TIR domain, and an N-terminal death domain associates with the TIR domain of the TLRs and upon binding of ligand to the receptor MyD88 recruits IRAK4 to the TLR receptor complex through the interaction of the death domains of both molecules and facilitates IRAK-4-mediated phosphorylation of IRAK-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m31*m17258*0.1
nodelay
--
0
PMID: 16930560 MyD88, which has a C-terminal TIR domain, and an N-terminal death domain associates with the TIR domain of the TLRs and upon binding of ligand to the receptor MyD88 recruits IRAK4 to the TLR receptor complex through the interaction of the death domains of both molecules and facilitates IRAK-4-mediated phosphorylation of IRAK-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m32*m33*0.1
nodelay
--
0
PMID: 16930560 The presence of IRAK-4 is required for the recruitment of IRAK-1 to the receptor complex and for the activation and subsequent degradation of IRAK-1 protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m35*0.1
nodelay
--
0
PMID: 16930560 MyD88, which has a C-terminal TIR domain, and an N-terminal death domain associates with the TIR domain of the TLRs and upon binding of ligand to the receptor MyD88 recruits IRAK4 to the TLR receptor complex through the interaction of the death domains of both molecules and facilitates IRAK-4-mediated phosphorylation of IRAK-1.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m3963*m3964*0.1
nodelay
--
0
PMID: 16930560 The other antibacterial TLRs are TLR2, which in combination with TLR1 recognises triacylated lipopeptides, or in combination with TLR6 recognises diacylated lipopeptides; and TLR5 which recognises bacterial flagellin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m34*0.1
nodelay
--
0
PMID: 16930560,11960013,8837778,11923871 Phosphorylated IRAK-1 subsequently dissociates from the receptor complex and associates with TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m183*m36*0.1
nodelay
--
0
PMID: 16930560,11960013,8837778,11923871 Phosphorylated IRAK-1 subsequently dissociates from the receptor complex and associates with TRAF6
p22
p22
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m39*m6433*m1583*0.1
nodelay
--
0
PMID: 16930560 IRAK1 binds TRAF6 which in turn binds a pre-formed membrane bound complex of TAB1/ TAK1/TAB2. PMID: 16930560 TRAF6 and IRAK1 then dissociate from the receptor complex and interact with a membrane bound pre-associated complex of TGF-b activated kinase (TAK1) and two TAK1-binding proteins (TAB), termed TAB1 and TAB2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m38*m40*0.1
nodelay
--
0
PMID: 16930560 IRAK1 binds TRAF6 which in turn binds a pre-formed membrane bound complex of TAB1/ TAK1/TAB2. PMID: 16930560 TRAF6 and IRAK1 then dissociate from the receptor complex and interact with a membrane bound pre-associated complex of TGF-b activated kinase (TAK1) and two TAK1-binding proteins (TAB), termed TAB1 and TAB2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m41*0.1
nodelay
--
0
PMID: 16930560,11460167,11518704,12242293 Ubiquitination of TRAF6 and TAK1 activate the complex, and phosphorylation of TAK1 and TAB2 initiates the release of the complex from the membrane PMID: 16930560 A series of ubiquitination reactions then occur on TRAF6 itself and on its substrate TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m42*0.1
nodelay
--
0
PMID: 16930560,11518704,12242293 Phosphorylation of TAK1 and TAB2 occurs initiating the dissociation of TRAF6/TAK1/TAB1/TAB2 from the membrane to the cytosol, and IRAK-1 degradation PMID: 16930560,11460167,11518704,12242293 Ubiquitination of TRAF6 and TAK1 activate the complex, and phosphorylation of TAK1 and TAB2 initiates the release of the complex from the membrane
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c112 : 1
m75*m92*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
p27
p27
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c40 : 1
stoichiometry:c77 : 1
stoichiometry:c41 : 1
m43*m26*0.1
nodelay
--
0
PMID: 16930560,11518704,12242293 Phosphorylation of TAK1 and TAB2 occurs initiating the dissociation of TRAF6/TAK1/TAB1/TAB2 from the membrane to the cytosol, and IRAK-1 degradation PMID: 16930560,11460167,11518704,12242293 Ubiquitination of TRAF6 and TAK1 activate the complex, and phosphorylation of TAK1 and TAB2 initiates the release of the complex from the membrane
p28
p28
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m44*m207*0.1
nodelay
--
0
PMID: 16930560,9346484 Active TAK1 phosphorylates the IKK complex, which in turn phosphorylates IkB targeting IkB for degradation PMID: 16930560 TAK1 is subsequently active and can then phosphorylate downstream targets such as the IkB kinases (IKKs).
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m19314*m18998*0.1
nodelay
--
0
PMID: 16930560 TRIF binds to TLR3 and recruits TRAF6 directly through a TRAF6-binding motif in its N-terminal domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m6*m11*0.1
nodelay
--
0
PMID: 16930560 The other antibacterial TLRs are TLR2, which in combination with TLR1 recognises triacylated lipopeptides, or in combination with TLR6 recognises diacylated lipopeptides; and TLR5 which recognises bacterial flagellin.
p29
p30
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m183*m19305*0.1
nodelay
--
0
PMID: 16930560 TRIF binds to TLR3 and recruits TRAF6 directly through a TRAF6-binding motif in its N-terminal domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m63*m41*0.1
nodelay
--
0
PMID: 16930560,14530355,12609980,14982987 TRIF binds to TLR3 and recruits TRAF6 directly through a TRAF6-binding motif in its N-terminal domain. This leads to TAK1 activation and subsequent NFkB activation in an IRAK1 and IRAK4 independent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c90 : 1
stoichiometry:c92 : 1
m64*m19305*0.1
nodelay
--
0
PMID: 16930560,15064760 The C-terminal of TRIF possesses a RIP homotypic interaction motif (RHIM), and it associates with receptor interacting protein 1 (RIP1) through homophilic interaction of RHIM domains. PMID: 16930560,15064760 TRIF also binds directly to RIP1 which binds TRAF6 and leads to the activation of the IKK complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m183*m65*0.1
nodelay
--
0
PMID: 16930560,15064760 TRIF also binds directly to RIP1 which binds TRAF6 and leads to the activation of the IKK complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m66*m41*0.1
nodelay
--
0
PMID: 16930560,15064760 TRIF also binds directly to RIP1 which binds TRAF6 and leads to the activation of the IKK complex
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m367*m31*0.1
nodelay
--
0
PMID: 16930560 Btk interacts with the TIR domain of TLR4 PMID: 16930560 More recently it has been found that Btk interacts with the TIR domains of many of the TLRs including that of TLR4 and also with Mal and MyD88, the adapters used by TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m67*m6810*0.1
nodelay
--
0
PMID: 16930560 On TLR ligation, TLR4 dimers and TLR2 heterodimerised with TLR1 or TLR6 recruit Mal and MyD88 to their TIR domains, TLR7/8/9 recruit MyD88 alone.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m68*0.1
nodelay
--
0
PMID: 16930560 LPS induces tyrosine phosphorylation of Btk and activates its kinase activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m69*0.1
nodelay
--
0
PMID: 16930560,15081522,12724322,15849198,16439361 It has since been shown that Btk directly phosphorylates Mal and functions on the pathway from TLR4 to the phosphorylation of the p65 subunit of NFkB, promoting transactivation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m91*0.1
nodelay
--
0
PMID: 16930560,10837071,9346484,9244310,9346485,9346241 Once activated the IKK complex induces phosphorylation and subsequent degradation of IkB, which leads to the translocation of NFkB culminating in NFkB activation and the expression of pro-inflammatory cytokines
p2
p4
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c10 : 1
stoichiometry:c12 : 1
m3987*m3964*0.1
nodelay
--
0
PMID: 16930560 The other antibacterial TLRs are TLR2, which in combination with TLR1 recognises triacylated lipopeptides, or in combination with TLR6 recognises diacylated lipopeptides; and TLR5 which recognises bacterial flagellin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m92*m77*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c161 : 1
m99*m10*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c182 : 1
m99*m100*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c123 : 1
m74*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression PMID: 16930560 As NFkB is a key transcription factor regulating the expression of IL-1b and TNFa they examined the ability of LPS to induce expression of Rel-family proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c124 : 1
m76*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c125 : 1
m78*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c130 : 1
m93309*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression PMID:16930560,16166516,16166517 TNFa expression is induced in an NFkB-independent IRF3-dependent manner, binds to the TNF receptor and induces NFkB activation providing delayed NFkB induction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c137 : 1
m79*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m93218*0.1
nodelay
--
0
PMID: 16930560,8011280 Once activated by a PAMP, a TLR triggers a cascade of cellular signals, culminating in the eventual activationofNFkBwhichbinds to a discretenucleotide sequence in the upstream regions of genes that produce proinflammatory cytokines, such as TNFa, IL-1, and IL-2, thereby regulating their expression
p49
p49
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c185 : 1
stoichiometry:c131 : 1
m93248*m92*0.1
nodelay
--
0
PMID: 16930560 At this point in time the ligands for TLRs were unknown and researchers only knew that by constitutively activating TLRs they could drive NFkB activation and cause the production of the proinflammatory cytokines TNFa, IL-1, IL-6 and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m13*m14*0.1
nodelay
--
0
PMID: 16930560 The other antibacterial TLRs are TLR2, which in combination with TLR1 recognises triacylated lipopeptides, or in combination with TLR6 recognises diacylated lipopeptides; and TLR5 which recognises bacterial flagellin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c186 : 1
stoichiometry:c135 : 1
m80*m92*0.1
nodelay
--
0
PMID: 16930560 At this point in time the ligands for TLRs were unknown and researchers only knew that by constitutively activating TLRs they could drive NFkB activation and cause the production of the proinflammatory cytokines TNFa, IL-1, IL-6 and IL-8.
p51
p51
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c3 : 1
stoichiometry:c141 : 1
m6254*m2828*0.1
nodelay
--
0
PMID: 16930560 LPS was known to be concentrated from the plasma by LPS binding protein (LBP), and CD14 was identified as a receptor for LPS on the surface of the cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c2 : 1
m6255*m3961*0.1
nodelay
--
0
PMID: 16930560 The best characterised is TLR4, which recognises the Gram-negative product lipopolysaccharide (LPS).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m46*m25*0.1
nodelay
--
0
PMID: 16930560,10837071,9346484,9244310,9346485,9346241 Once activated the IKK complex induces phosphorylation and subsequent degradation of IkB, which leads to the translocation of NFkB culminating in NFkB activation and the expression of pro-inflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c147 : 1
stoichiometry:c149 : 1
m82*0.1
nodelay
--
0
PMID: 16930560,10837071,9346484,9244310,9346485,9346241 Once activated the IKK complex induces phosphorylation and subsequent degradation of IkB, which leads to the translocation of NFkB culminating in NFkB activation and the expression of pro-inflammatory cytokines
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c152 : 1
stoichiometry:c151 : 1
m5*m84*0.1
nodelay
--
0
PMID; 16930560,8258685 Soon afterwards it was reported that PTKs were required for the induction of the pro-inflammatory cytokines IL-1b, IL-6 and TNFa in response to LPS in murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c155 : 1
stoichiometry:c154 : 1
m5*m84*0.1
nodelay
--
0
PMID; 16930560,8258685 Soon afterwards it was reported that PTKs were required for the induction of the pro-inflammatory cytokines IL-1b, IL-6 and TNFa in response to LPS in murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m5*m84*0.1
nodelay
--
0
PMID; 16930560,8258685 Soon afterwards it was reported that PTKs were required for the induction of the pro-inflammatory cytokines IL-1b, IL-6 and TNFa in response to LPS in murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c160 : 1
m92*0.1
nodelay
--
0
PMID: 16930560 As NFkB is a key transcription factor regulating the expression of IL-1b and TNFa they examined the ability of LPS to induce expression of Rel-family proteins.
p2
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m6485*m3966*0.1
nodelay
--
0
PMID: 16930560 The other antibacterial TLRs are TLR2, which in combination with TLR1 recognises triacylated lipopeptides, or in combination with TLR6 recognises diacylated lipopeptides; and TLR5 which recognises bacterial flagellin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m230*m86*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m81*m88*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m87*m71*0.1
nodelay
--
0
PMID: 16930560 To date, five distinct serine residues have been identified on the p65 NFkB subunit that are inducibly phosphorylated in response to LPS, TNFa, and IL-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m89*m71*0.1
nodelay
--
0
PMID: 16930560 To date, five distinct serine residues have been identified on the p65 NFkB subunit that are inducibly phosphorylated in response to LPS, TNFa, and IL-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c36 : 1
stoichiometry:c178 : 1
m5*m71*m90*0.1
nodelay
--
0
PMID: 16930560 To date, five distinct serine residues have been identified on the p65 NFkB subunit that are inducibly phosphorylated in response to LPS, TNFa, and IL-1. PMID: 16930560,9660950,9150141 Serine 276 in the RHD on p65 is phosphorylated by protein kinase A (PKA) in response to LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c114 : 1
stoichiometry:c181 : 1
m2282*m85*0.1
nodelay
--
0
PMID: 16930560,11931769,9660950 Zhong et al. found that LPS stimulated PKAdependent phosphorylation of p65 on serine 276 promotes its interaction with the coactivator CREB-binding protein (CBP), potentiating NFkB transcription
p66
p66
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c133 : 1
stoichiometry:c136 : 1
stoichiometry:c159 : 1
m181*m182*m1593*0.1
nodelay
--
0
p67
p67
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
stoichiometry:c190 : 1
m5*m182*m71*0.1
nodelay
--
0
PMID: 16930560 They found that IKKb plays an essential role in LPS-induced serine 536 phosphorylation in MEFs,while IKKa is only partially required for serine 536 phosphorylation
p67
p68
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c192 : 1
stoichiometry:c193 : 1
stoichiometry:c194 : 1
m5*m181*m71*0.1
nodelay
--
0
PMID: 16930560 They found that IKKb plays an essential role in LPS-induced serine 536 phosphorylation in MEFs,while IKKa is only partially required for serine 536 phosphorylation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c196 : 1
stoichiometry:c197 : 1
m92*m72*0.1
nodelay
--
0
PMID: 16930560,11356851 A new nuclear IkB protein, IkBz, arrived on the scene relatively recently, which has been shown to interact with NFkB via a Cterminal ankyrin repeat domain in the nucleus
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 16930560 The anti-viral TLRs are TLR3 which recognises double stranded RNA, TLR7 and TLR8 which bothrecognise single strandedRNA,andTLR9which recognises CpGmotifs, that exist in both virus and bacteria
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m67*0.1
nodelay
--
0
PMID: 16930560 IkBz is barely detectable in resting cells but it is dramatically induced in response to TLR ligands such as LPS, lipopeptides and CpG DNA, in a MyD88 dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m94*0.1
nodelay
--
0
PMID: 16930560 IkBz is barely detectable in resting cells but it is dramatically induced in response to TLR ligands such as LPS, lipopeptides and CpG DNA, in a MyD88 dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
m72*0.1
nodelay
--
0
PMID:16930560 IkBz is essential for the induction of a subset of inflammatory genes including IL-6 and the IL-12p40 subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c204 : 1
stoichiometry:c205 : 1
m72*0.1
nodelay
--
0
PMID:16930560 IkBz is essential for the induction of a subset of inflammatory genes including IL-6 and the IL-12p40 subunit.
p74
p74
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c207 : 1
m93248*m72*m5*0.1
nodelay
--
0
PMID: 16930560,15618216 Interestingly overexpression of IkBz results in an augmentation of IL-6 production in response to LPS, but inhibits TNFa production
p74
p75
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c213 : 1
stoichiometry:c211 : 1
m93309*m5*0.1
nodelay
--
0
PMID: 16930560,15618216 Interestingly overexpression of IkBz results in an augmentation of IL-6 production in response to LPS, but inhibits TNFa production
p76
p76
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c215 : 1
stoichiometry:c216 : 1
m19305*m3902*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes PMID: 16930560,14530355 TRIF can also interact with TBK1/IKKe which leads to the activation of IRF3
p76
p77
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c217 : 1
stoichiometry:c218 : 1
stoichiometry:c219 : 1
m19305*m1599*0.1
nodelay
--
0
PMID: 16930560,14530355 TRIF can also interact with TBK1/IKKe which leads to the activation of IRF3
p78
p78
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c221 : 1
stoichiometry:c222 : 1
m95*m977*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes PMID: 16930560,14530355 TRIF can also interact with TBK1/IKKe which leads to the activation of IRF3
p78
p79
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c225 : 1
m96*m977*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes PMID: 16930560,14530355 TRIF can also interact with TBK1/IKKe which leads to the activation of IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m17*m19940*0.1
nodelay
--
0
PMID: 16930560 The anti-viral TLRs are TLR3 which recognises double stranded RNA, TLR7 and TLR8 which bothrecognise single strandedRNA,andTLR9which recognises CpGmotifs, that exist in both virus and bacteria
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m97*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c229 : 1
m98*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c234 : 1
m101*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes PMID:16930560,12471095 IFN inducible genes are induced via the activation of IRF3 and other interferon inducible factors. LPS induction of IFN-inducible genes encoding IP-10, GARG-16 and IRG-1 was comparable in wild type,Mal-deficient andMyD88-deficientmacrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c239 : 1
m103*0.1
nodelay
--
0
PMID: 16930560,14517278 TLR3 recruits TRIF to its TIR domain which interacts with TBK1 activating IRF3 which binds as a dimer to the ISRE site of the IFNb and IP-10 genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c241 : 1
stoichiometry:c242 : 1
m5*m19005*0.1
nodelay
--
0
PMID: 16930560 TLR4 recruits TRAM to its TIR domain which in turn recruits TRIF and activates TBK1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c244 : 1
stoichiometry:c245 : 1
m18998*m104*0.1
nodelay
--
0
PMID: 16930560 TLR4 recruits TRAM to its TIR domain which in turn recruits TRIF and activates TBK1
p88
p88
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c246 : 1
stoichiometry:c248 : 1
m106*m105*0.1
nodelay
--
0
PMID: 16930560 TLR4 recruits TRAM to its TIR domain which in turn recruits TRIF and activates TBK1
p88
p89
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c250 : 1
stoichiometry:c251 : 1
m3902*m977*0.1
nodelay
--
0
PMID: 16930560 TBK1 activates IRF3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m17*m19823*0.1
nodelay
--
0
PMID: 16930560 The anti-viral TLRs are TLR3 which recognises double stranded RNA, TLR7 and TLR8 which bothrecognise single strandedRNA,andTLR9which recognises CpGmotifs, that exist in both virus and bacteria
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c252 : 1
stoichiometry:c253 : 1
stoichiometry:c257 : 1
stoichiometry:c258 : 1
stoichiometry:c254 : 1
m92*m99*m5*0.1
nodelay
--
0
PMID: 16930560 Under LPS stimulation p65 homodimers appear to interactwith IRF3 to activate the IP-10 gene PMID: 16930560,16143103 This IRF3/p65 complex is susceptible to glucocorticoid inhibition
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c256 : 1
m107*0.1
nodelay
--
0
PMID: 16930560 Under LPS stimulation p65 homodimers appear to interactwith IRF3 to activate the IP-10 gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c259 : 1
stoichiometry:c260 : 1
m99*0.1
nodelay
--
0
PMID:16930560,12471095 IFN inducible genes are induced via the activation of IRF3 and other interferon inducible factors. LPS induction of IFN-inducible genes encoding IP-10, GARG-16 and IRG-1 was comparable in wild type,Mal-deficient andMyD88-deficientmacrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c261 : 1
stoichiometry:c262 : 1
m99*0.1
nodelay
--
0
PMID:16930560,12471095 IFN inducible genes are induced via the activation of IRF3 and other interferon inducible factors. LPS induction of IFN-inducible genes encoding IP-10, GARG-16 and IRG-1 was comparable in wild type,Mal-deficient andMyD88-deficientmacrophages
p94
p94
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c263 : 1
stoichiometry:c265 : 1
stoichiometry:c264 : 1
m111*m5*0.1
nodelay
--
0
PMID:16930560,10565609 Orlicek et al., directly implicated Src kinases in LPS signalling to TNFa and iNOS (inducible nitric oxide synthase) induction with the use of the Src-selective inhibitor PP1, in murine macrophages
p94
p95
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c266 : 1
stoichiometry:c268 : 1
stoichiometry:c267 : 1
m111*m5*0.1
nodelay
--
0
PMID:16930560,10565609 Orlicek et al., directly implicated Src kinases in LPS signalling to TNFa and iNOS (inducible nitric oxide synthase) induction with the use of the Src-selective inhibitor PP1, in murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c270 : 1
m99*0.1
nodelay
--
0
PMID:16930560,16166516,16166517 TNFa expression is induced in an NFkB-independent IRF3-dependent manner, binds to the TNF receptor and induces NFkB activation providing delayed NFkB induction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c271 : 1
stoichiometry:c272 : 1
stoichiometry:c273 : 1
m71*m87*0.1
nodelay
--
0
PMID:16930560,16166516,16166517 TNFa expression is induced in an NFkB-independent IRF3-dependent manner, binds to the TNF receptor and induces NFkB activation providing delayed NFkB induction
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--